查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1697924

全球神经可塑性增强设备市场：市场规模、占有率、趋势、产业分析（按产品类型、应用、最终用户和地区）、未来预测（2025-2034）

Neuroplasticity Enhancement Devices Market Size, Share, Trends, Industry Analysis Report: By Product Type, Application, End User, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 129 Pages | 商品交期: 最快1-2个工作天内

价格

根据 Polaris Market Research 的一项新研究，全球神经可塑性增强设备市场预计到 2034 年将达到 714 亿美元。该研究报告提供了对当前市场动态的详细洞察，并对未来市场成长进行了分析。

神经可塑性，即大脑透过形成新的神经连结来重组自身的能力，已成为神经科学、认知科学和医学研究的重点。最近的趋势是，技术进步推动了神经可塑性增强设备的发展，旨在优化大脑功能、促进学习、帮助康復，甚至增强超越自然极限的认知能力。这些设备使用多种技术，包括电刺激和磁刺激、脑波调节、神经反馈和感觉增强，来诱导神经可塑性变化。

经颅磁刺激 (TMS) 是一种广泛使用的设备，它利用磁场在大脑中感应电流，促进神经重组。TMS 已被批准用于治疗忧郁症，并且还被证明可有效治疗其他神经系统疾病，包括帕金森氏症和慢性疼痛。

这些设备允许用户即时监控和调整他们的大脑活动。基于脑电图 (EEG) 的神经回馈设备追踪脑电波模式并透过视觉、听觉或触觉提示提供回馈，以帮助使用者训练大脑活动达到所需状态。脑机介面（BCI）在增强神经可塑性方面也发挥着重要作用。BCI 对瘫痪和神经退化性疾病患者俱有特别大的改变作用，使他们能够重新获得功能独立性。

神经可塑性增强设备市场：分析概述

根据产品类型，经颅磁刺激 (TMS) 设备占据了 2024 年神经可塑性增强设备市场的最大占有率，这归功于其在治疗神经和精神疾病方面的有效性。

从最终用户来看，随着个人寻求方便且经济高效的认知增强和神经復健解决方案，家庭医疗保健领域预计将在未来几年占据主导地位。

2024 年，北美凭藉其强大的医疗保健基础设施、先进神经技术的高采用率以及神经系统疾病的日益流行，占据了全球神经可塑性增强设备市场的收入占有率。

由于城市化进程加快、医疗保健支出增加以及大脑意识增强，预计未来几年亚太市场将会成长。

一些世界领先的公司包括 BioSerenity、Blackrock Neurotech、BrainCo、BrainsWay、Ceribell、EMOTIV、Flow Neuroscience、Neurable、Neuralink、NeuroPace、Paradromics 和 Synchron。

目录

第1章 引言

第2章 执行摘要

第3章分析方法

第4章全球神经可塑性增强设备市场洞察

  • 市场快照
  • 神经可塑性增强设备的市场动态
    • 推动因素和机遇
      • 全球老龄人口正在增加
      • 年轻人忧郁症盛行率不断上升
    • 阻碍因素和课题
      • 成本高、认知度低
  • PESTLE 分析
  • 神经可塑性增强设备市场趋势
  • 价值链分析
  • COVID-19 影响分析

第5章全球神经可塑性增强设备市场（按产品类型）

  • 主要发现
  • 介绍
  • 经颅磁刺激（TMS）装置
  • 经颅直流电刺激（tDCS）装置
  • 基于脑电图（EEG）的设备
  • 其他

第6章 全球神经可塑性增强设备市场（依应用）

  • 主要发现
  • 介绍
  • 提升认知能力
  • 中风和脑外伤康復
  • 精神健康与神经系统疾病
  • 提升学习和记忆力
  • 其他

第7章 全球神经可塑性增强设备市场（依最终用户）

  • 主要发现
  • 介绍
  • 医院/诊所
  • 研究机构和学术中心
  • 家庭医疗
  • 其他

第8章 全球神经可塑性增强设备市场（按地区）

  • 主要发现
  • 介绍
    • 神经可塑性增强设备市场（按地区）分析（2020-2034）
  • 北美
    • 北美：依产品类型（2020-2034 年）
    • 北美应用情形（2020-2034）
    • 北美：按最终用户划分（2020-2034 年）
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲：依产品类型（2020-2034 年）
    • 欧洲：按应用划分（2020-2034 年）
    • 欧洲：依最终用户划分（2020-2034 年）
    • 英国
    • 法国
    • 德国
    • 义大利
    • 西班牙
    • 荷兰
    • 俄罗斯
    • 欧洲其他地区
  • 亚太地区
    • 亚太地区产品类型（2020-2034）
    • 亚太地区应用情况（2020-2034）
    • 亚太地区最终用户分布（2020-2034）
    • 中国
    • 印度
    • 马来西亚
    • 日本
    • 印尼
    • 韩国
    • 澳洲
    • 其他亚太地区
  • 中东/非洲
    • 中东和非洲：按产品类型（2020-2034 年）
    • 中东和非洲的应用（2020-2034）
    • 中东和非洲：按最终用户划分（2020-2034 年）
    • 沙乌地阿拉伯
    • 阿拉伯联合酋长国
    • 以色列
    • 南非
    • 其他中东/非洲
  • 拉丁美洲
    • 2020-2034 年拉丁美洲产品类型
    • 拉丁美洲应用情况（2020-2034）
    • 拉丁美洲最终用户分布（2020-2034）
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他拉丁美洲

第9章竞争格局

  • 业务扩展和收购分析
    • 业务拓展
    • 收购
  • 伙伴关係/协作/协议/揭露

第10章 公司简介

  • BioSerenity
  • Blackrock Neurotech
  • BrainCo Inc.
  • BrainsWay
  • Ceribell, Inc.
  • EMOTIV
  • Flow Neuroscience
  • Neurable
  • Neuralink
  • NeuroPace, Inc.
  • Paradromics
  • Synchron
Product Code: PM5416

The global neuroplasticity enhancement devices market size is expected to reach USD 71.40 billion by 2034, according to a new study by Polaris Market Research. The report "Neuroplasticity Enhancement Devices Market Size, Share, Trends, Industry Analysis Report: By Product Type [Transcranial Magnetic Stimulation (TMS) Devices, Transcranial Direct Current Stimulation (tDCS) Devices, Electroencephalogram (EEG)-Based Devices, and Others], Application, End User, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Neuroplasticity, the brain's ability to reorganize itself by forming new neural connections, has been a major focus in neuroscience, cognitive science, and medical research. In recent years, advancements in technology have led to the development of neuroplasticity enhancement devices, which aim to optimize brain function, accelerate learning, aid in rehabilitation, and even enhance cognitive abilities beyond natural limits. These devices use a variety of techniques, including electrical and magnetic stimulation, brainwave modulation, neurofeedback, and sensory augmentation, to encourage neuroplastic changes.

Transcranial magnetic stimulation (TMS) is a widely used device that employs magnetic fields to induce electric currents in the brain, facilitating neural reorganization. TMS has been approved for treating depression and has shown effectiveness in treating other neurological disorders, such as Parkinson's disease and chronic pain conditions.

These device allow users to monitor and regulate their brain activity in real time, providing a form of self-directed neuroplasticity training. Electroencephalography (EEG)-based neurofeedback devices track brainwave patterns and provide feedback through visual, auditory, or haptic cues, helping users train their brain activity toward desired states. Brain-computer interfaces (BCIs) are also playing a crucial role in neuroplasticity enhancement. BCIs have been particularly transformative for individuals affected by paralysis or neurodegenerative conditions, enabling them to regain functional independence.

Neuroplasticity Enhancement Devices Market Report Highlights

In terms of product type, the transcranial magnetic stimulation (TMS) devices segment held the largest neuroplasticity enhancement devices market share in 2024 due to their proven effectiveness in treating neurological and psychiatric disorders.

Based on end user, the home care settings segment is projected to hold a dominant share in the coming years as individuals seek convenient, cost-effective solutions for cognitive enhancement and neurological rehabilitation.

North America dominated the global neuroplasticity enhancement devices market revenue share in 2024 due to its strong healthcare infrastructure, high adoption of advanced neurotechnology, and increasing prevalence of neurological disorders.

The market in Asia Pacific is expected to grow in the coming years, owing to rapid urbanization, increasing healthcare expenditures, and growing awareness of the brain.

A few of the global key market players are BioSerenity; Blackrock Neurotech; BrainCo Inc.; BrainsWay; Ceribell, Inc.; EMOTIV; Flow Neuroscience; Neurable; Neuralink; NeuroPace, Inc.; Paradromics; and Synchron.

Polaris Market Research has segmented the neuroplasticity enhancement devices market report on the basis of product type, application, end user, and region:

By Product Type Outlook (Revenue, USD Billion, 2020-2034)

  • Transcranial Magnetic Stimulation (TMS) Devices
  • Transcranial Direct Current Stimulation (tDCS) Devices
  • Electroencephalogram (EEG)-Based Devices
  • Others

By Application Mode Outlook (Revenue, USD Billion, 2020-2034)

  • Cognitive Enhancement
  • Stroke & Traumatic Brain Injury Recovery
  • Mental Health & Neurological Disorders
  • Learning & Memory Improvement
  • Others

By End User Outlook (Revenue, USD Billion, 2020-2034)

  • Hospitals & Clinics
  • Research Institutions & Academic Centers
  • Home Care Settings
  • Others

By Regional Outlook (Revenue, USD Billion, 2020-2034)

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Netherlands
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Malaysia
  • South Korea
  • Indonesia
  • Australia
  • Vietnam
  • Rest of Asia Pacific
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa
  • Rest of Middle East & Africa
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Source
    • 3.2.1. Primary Source
    • 3.2.2. Secondary Source

4. Global Neuroplasticity Enhancement Devices Market Insights

  • 4.1. Neuroplasticity Enhancement Devices Market - Market Snapshot
  • 4.2. Neuroplasticity Enhancement Devices Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing Geriatric Population Globally
      • 4.2.1.2. Growing Prevalence of Depression Among Young Population
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High cost and lack of awareness
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Neuroplasticity Enhancement Devices Market Trends
  • 4.6. Value Chain Analysis

5. Global Neuroplasticity Enhancement Devices Market, by Product Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  • 5.3. Transcranial Magnetic Stimulation (TMS) Devices
    • 5.3.1. Global Neuroplasticity Enhancement Devices Market, by Transcranial Magnetic Stimulation (TMS) Devices, by Region, 2020-2034 (USD Billion)
  • 5.4. Transcranial Direct Current Stimulation (tDCS) Devices
    • 5.4.1. Global Neuroplasticity Enhancement Devices Market, by Transcranial Direct Current Stimulation (tDCS) Devices, by Region, 2020-2034 (USD Billion)
  • 5.5. Electroencephalogram (EEG)-Based Devices
    • 5.5.1. Global Neuroplasticity Enhancement Devices Market, by Electroencephalogram (EEG)-Based Devices, by Region, 2020-2034 (USD Billion)
  • 5.6. Others
    • 5.6.1. Global Neuroplasticity Enhancement Devices Market, by Others, by Region, 2020-2034 (USD Billion)

6. Global Neuroplasticity Enhancement Devices Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  • 6.3. Cognitive Enhancement
    • 6.3.1. Global Neuroplasticity Enhancement Devices Market, by Cognitive Enhancement, by Region, 2020-2034 (USD Billion)
  • 6.4. Stroke & Traumatic Brain Injury Recovery
    • 6.4.1. Global Neuroplasticity Enhancement Devices Market, by Stroke & Traumatic Brain Injury Recovery, by Region, 2020-2034 (USD Billion)
  • 6.5. Mental Health & Neurological Disorders
    • 6.5.1. Global Neuroplasticity Enhancement Devices Market, by Mental Health & Neurological Disorders, by Region, 2020-2034 (USD Billion)
  • 6.6. Learning & Memory Improvement
    • 6.6.1. Global Neuroplasticity Enhancement Devices Market, by Learning & Memory Improvement, by Region, 2020-2034 (USD Billion)
  • 6.7. Others
    • 6.7.1. Global Neuroplasticity Enhancement Devices Market, by Others, by Region, 2020-2034 (USD Billion)

7. Global Neuroplasticity Enhancement Devices Market, by End User

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • 7.3. Hospitals & Clinics
    • 7.3.1. Global Neuroplasticity Enhancement Devices Market, by Hospitals & Clinics, by Region, 2020-2034 (USD Billion)
  • 7.4. Research Institutions & Academic Centers
    • 7.4.1. Global Neuroplasticity Enhancement Devices Market, by Research Institutions & Academic Centers, by Region, 2020-2034 (USD Billion)
  • 7.5. Home Care Settings
    • 7.5.1. Global Neuroplasticity Enhancement Devices Market, by Home Care Settings, by Region, 2020-2034 (USD Billion)
  • 7.6. Others
    • 7.6.1. Global Neuroplasticity Enhancement Devices Market, by Others, by Region, 2020-2034 (USD Billion)

8. Global Neuroplasticity Enhancement Devices Market, by Geography

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Neuroplasticity Enhancement Devices Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 8.3. Neuroplasticity Enhancement Devices Market - North America
    • 8.3.1. North America: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
    • 8.3.2. North America: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
    • 8.3.3. North America: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
    • 8.3.4. Neuroplasticity Enhancement Devices Market - U.S.
      • 8.3.4.1. U.S.: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
      • 8.3.4.2. U.S.: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
      • 8.3.4.3. U.S.: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
    • 8.3.5. Neuroplasticity Enhancement Devices Market - Canada
      • 8.3.5.1. Canada: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
      • 8.3.5.2. Canada: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
      • 8.3.5.3. Canada: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • 8.4. Neuroplasticity Enhancement Devices Market - Europe
    • 8.4.1. Europe: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
    • 8.4.2. Europe: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
    • 8.4.3. Europe: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
    • 8.4.4. Neuroplasticity Enhancement Devices Market - UK
      • 8.4.4.1. UK: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
      • 8.4.4.2. UK: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
      • 8.4.4.3. UK: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
    • 8.4.5. Neuroplasticity Enhancement Devices Market - France
      • 8.4.5.1. France: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
      • 8.4.5.2. France: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
      • 8.4.5.3. France: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
    • 8.4.6. Neuroplasticity Enhancement Devices Market - Germany
      • 8.4.6.1. Germany: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
      • 8.4.6.2. Germany: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
      • 8.4.6.3. Germany: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
    • 8.4.7. Neuroplasticity Enhancement Devices Market - Italy
      • 8.4.7.1. Italy: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
      • 8.4.7.2. Italy: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
      • 8.4.7.3. Italy: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
    • 8.4.8. Neuroplasticity Enhancement Devices Market - Spain
      • 8.4.8.1. Spain: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
      • 8.4.8.2. Spain: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
      • 8.4.8.3. Spain: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
    • 8.4.9. Neuroplasticity Enhancement Devices Market - Netherlands
      • 8.4.9.1. Netherlands: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
      • 8.4.9.2. Netherlands: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
      • 8.4.9.3. Netherlands: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
    • 8.4.10. Neuroplasticity Enhancement Devices Market - Russia
      • 8.4.10.1. Russia: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
      • 8.4.10.2. Russia: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
      • 8.4.10.3. Russia: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
    • 8.4.11. Neuroplasticity Enhancement Devices Market - Rest of Europe
      • 8.4.11.1. Rest of Europe: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
      • 8.4.11.2. Rest of Europe: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
      • 8.4.11.3. Rest of Europe: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • 8.5. Neuroplasticity Enhancement Devices Market - Asia Pacific
    • 8.5.1. Asia Pacific: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
    • 8.5.2. Asia Pacific: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
    • 8.5.3. Asia Pacific: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
    • 8.5.4. Neuroplasticity Enhancement Devices Market - China
      • 8.5.4.1. China: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
      • 8.5.4.2. China: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
      • 8.5.4.3. China: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
    • 8.5.5. Neuroplasticity Enhancement Devices Market - India
      • 8.5.5.1. India: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
      • 8.5.5.2. India: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
      • 8.5.5.3. India: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
    • 8.5.6. Neuroplasticity Enhancement Devices Market - Malaysia
      • 8.5.6.1. Malaysia: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
      • 8.5.6.2. Malaysia: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
      • 8.5.6.3. Malaysia: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
    • 8.5.7. Neuroplasticity Enhancement Devices Market - Japan
      • 8.5.7.1. Japan: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
      • 8.5.7.2. Japan: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
      • 8.5.7.3. Japan: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
    • 8.5.8. Neuroplasticity Enhancement Devices Market - Indonesia
      • 8.5.8.1. Indonesia: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
      • 8.5.8.2. Indonesia: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
      • 8.5.8.3. Indonesia: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
    • 8.5.9. Neuroplasticity Enhancement Devices Market - South Korea
      • 8.5.9.1. South Korea: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
      • 8.5.9.2. South Korea: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
      • 8.5.9.3. South Korea: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
    • 8.5.10. Neuroplasticity Enhancement Devices Market - Australia
      • 8.5.10.1. Australia: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
      • 8.5.10.2. Australia: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
      • 8.5.10.3. Australia: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
    • 8.5.11. Neuroplasticity Enhancement Devices Market - Rest of Asia Pacific
      • 8.5.11.1. Rest of Asia Pacific: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
      • 8.5.11.2. Rest of Asia Pacific: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
      • 8.5.11.3. Rest of Asia Pacific: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • 8.6. Neuroplasticity Enhancement Devices Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
    • 8.6.2. Middle East & Africa: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
    • 8.6.3. Middle East & Africa: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
    • 8.6.4. Neuroplasticity Enhancement Devices Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
      • 8.6.4.2. Saudi Arabia: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
    • 8.6.5. Neuroplasticity Enhancement Devices Market - UAE
      • 8.6.5.1. UAE: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
      • 8.6.5.2. UAE: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
      • 8.6.5.3. UAE: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
    • 8.6.6. Neuroplasticity Enhancement Devices Market - Israel
      • 8.6.6.1. Israel: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
      • 8.6.6.2. Israel: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
      • 8.6.6.3. Israel: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
    • 8.6.7. Neuroplasticity Enhancement Devices Market - South Africa
      • 8.6.7.1. South Africa: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
      • 8.6.7.2. South Africa: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
      • 8.6.7.3. South Africa: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
    • 8.6.8. Neuroplasticity Enhancement Devices Market - Rest of Middle East & Africa
      • 8.6.8.1. Rest of Middle East & Africa: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
      • 8.6.8.2. Rest of Middle East & Africa: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
      • 8.6.8.3. Rest of Middle East & Africa: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • 8.7. Neuroplasticity Enhancement Devices Market - Latin America
    • 8.7.1. Latin America: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
    • 8.7.2. Latin America: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
    • 8.7.3. Latin America: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
    • 8.7.4. Neuroplasticity Enhancement Devices Market - Mexico
      • 8.7.4.1. Mexico: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
      • 8.7.4.2. Mexico: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
      • 8.7.4.3. Mexico: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
    • 8.7.5. Neuroplasticity Enhancement Devices Market - Brazil
      • 8.7.5.1. Brazil: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
      • 8.7.5.2. Brazil: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
      • 8.7.5.3. Brazil: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
    • 8.7.6. Neuroplasticity Enhancement Devices Market - Argentina
      • 8.7.6.1. Argentina: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
      • 8.7.6.2. Argentina: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
      • 8.7.6.3. Argentina: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
    • 8.7.7. Neuroplasticity Enhancement Devices Market - Rest of Latin America
      • 8.7.7.1. Rest of Latin America: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
      • 8.7.7.2. Rest of Latin America: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
      • 8.7.7.3. Rest of Latin America: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. BioSerenity
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Blackrock Neurotech
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. BrainCo Inc.
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. BrainsWay
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Ceribell, Inc.
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. EMOTIV
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Flow Neuroscience
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Neurable
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Neuralink
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. NeuroPace, Inc.
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Paradromics
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Synchron
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development

List of Tables:

  • Table 1 Global Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  • Table 2 Global Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 3 Global Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • Table 4 North America: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  • Table 5 North America: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 6 North America: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • Table 7 U.S.: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  • Table 8 U.S.: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 9 U.S.: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • Table 10 Canada: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  • Table 11 Canada: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 12 Canada: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • Table 13 Europe: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  • Table 14 Europe: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 15 Europe: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • Table 16 UK: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  • Table 17 UK: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 18 UK: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • Table 19 France: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  • Table 20 France: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 21 France: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • Table 22 Germany: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  • Table 23 Germany: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 24 Germany: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • Table 25 Italy: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  • Table 26 Italy: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 27 Italy: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • Table 28 Spain: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  • Table 29 Spain: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 30 Spain: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • Table 31 Netherlands: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  • Table 32 Netherlands: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 33 Netherlands: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • Table 34 Russia: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  • Table 35 Russia: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 36 Russia: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • Table 37 Rest of Europe: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  • Table 38 Rest of Europe: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 39 Rest of Europe: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • Table 40 Asia Pacific: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  • Table 41 Asia Pacific: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 42 Asia Pacific: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • Table 43 China: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  • Table 44 China: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 45 China: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • Table 46 India: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  • Table 47 India: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 48 India: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • Table 49 Malaysia: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  • Table 50 Malaysia: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 51 Malaysia: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • Table 52 Japan: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  • Table 53 Japan: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 54 Japan: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • Table 55 Indonesia: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  • Table 56 Indonesia: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 57 Indonesia: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • Table 58 South Korea: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  • Table 59 South Korea: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 60 South Korea: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • Table 61 Australia: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  • Table 62 Australia: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 63 Australia: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • Table 64 Rest of Asia Pacific: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  • Table 65 Rest of Asia Pacific: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 66 Rest of Asia Pacific: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • Table 67 Middle East & Africa: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  • Table 68 Middle East & Africa: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 69 Middle East & Africa: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • Table 70 Saudi Arabia: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  • Table 71 Saudi Arabia: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 72 Saudi Arabia: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • Table 73 UAE: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  • Table 74 UAE: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 75 UAE: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • Table 76 Israel: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  • Table 77 Israel: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 78 Israel: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • Table 79 South Africa: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  • Table 80 South Africa: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 81 South Africa: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • Table 82 Rest of Middle East & Africa: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  • Table 83 Rest of Middle East & Africa: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 84 Rest of Middle East & Africa: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • Table 85 Latin America: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  • Table 86 Latin America: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 87 Latin America: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • Table 88 Mexico: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  • Table 89 Mexico: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 90 Mexico: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • Table 91 Brazil: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  • Table 92 Brazil: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 93 Brazil: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • Table 94 Argentina: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  • Table 95 Argentina: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 96 Argentina: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • Table 97 Rest of Latin America: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  • Table 98 Rest of Latin America: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 99 Rest of Latin America: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)

List of Figures:

  • Figure 1. Global Neuroplasticity Enhancement Devices Market, 2020-2034 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Product Type
  • Figure 7. Global Neuroplasticity Enhancement Devices Market, by Product Type, 2024 & 2034 (USD Billion)
  • Figure 8. Market by Application
  • Figure 9. Global Neuroplasticity Enhancement Devices Market, by Application, 2024 & 2034 (USD Billion)
  • Figure 10. Market by End User
  • Figure 11. Global Neuroplasticity Enhancement Devices Market, by End User, 2024 & 2034 (USD Billion)